Review Article - (2013) Volume 0, Issue 0
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis
- Mark S Freedman1, Johanne M Kaplan2 and Silva Markovic-Plese3*
- 1University of Ottawa, Multiple Sclerosis Research Clinic, the Ottawa Hospital-General Campus, Ottawa, Ontario K1H 8L6, Canada
- 2Genzyme, a Sanofi Company, Framingham, MA 01701, USA
- 3Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, NC 27599-7025, USA
*Corresponding Author:
Silva Markovic-Plese,
MD, PhD, University of North Carolina at Chapel Hill, 105 Mason Farm Road, Neuroscience Research Building, Room 6129, Chapel Hill, NC 27599, USA, Tel: 919 966 3701, Fax: 919 843 4576
Email:
